| ABCB1 | Adenosine-triphosphate-binding cassette sub-family B member 1 |
| ACTB | beta-actin gene |
| ASCT | autologous stem cell transplantation |
| BM | bone marrow |
| CXCR-4 | C-X-C chemokine receptor type 4 |
| DLBCL | diffuse large B-cell lymphoma |
| ECM | extracellular matrix |
| FWER | family-wise error rate |
| IPO8 | Importin 8 gene |
| IsaRVD | isatuximab, lenalidomide, bortezomib, dexamethasone |
| MAF | musculoaponeurotic fibrosarcoma |
| MARCKS | myristoylated alanine-rich C-kinase substrate |
| MM | multiple myeloma |
| MT-ATP6 | mitochondrially Encoded ATP Synthase Membrane Subunit 6 gene |
| NRF2 | nuclear factor erythroid 2-related factor 2 |
| NF-κB | nuclear factor kappa B |
| OS | overall survival |
| PC | plasma cells |
| POMP | proteasome maturation protein |
| PFS | progression free survival |
| PI | proteasome inhibitor |
| PSMB5 | proteasome subunit β type 5 |
| RPLP0 | Ribosomal Protein Lateral Stalk Subunit P0 gene |
| RPL5 | ribosomal protein L5 |
| UPR | unfolded protein response |
| TXN | thioredoxin |
| VCD | bortezomib, cyclophosphamide, dexamethasone |
| VD | bortezomib and dexamethasone |
| VMP | bortezomib, melphalan and prednisone. |
| VTD | bortezomib, thalidomide, dexamethasone |
| TXN | thioredoxin |
| XBP1 | X-box binding protein 1 |